Dr. Ebru KARCI

experiences

2008 – 2012
Kocaeli University Department of Internal Medicine.

certificates

2017
Ankara University Faculty of Medicine, Medical Oncology
2012
Kocaeli University Faculty of Medicine, Internal Medicine
2004
Istanbul University Cerrahpaşa Faculty of Medicine, Faculty of Medicine

publications

A. Articles published in international refereed journals:
A1. 1.a.1. Alkan A, Guc ZG, Senler FC, Yavuzsen T, Onur H, Dogan M, Karci E, Yasar A, Koksoy EB, Tanriverdi O, Turhal S, Urun Y, Ozkan A, Mizrak D, Akbulut H. Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the TurkishOncology Group (TOG) Support Care Cancer. 2016 Sep;24(9):3747-55. doi: 10.1007/s00520-016-3202-6. Epub 2016 Apr 2.
1.a.2. Alkan A, Yaşar A, Karcı E, Köksoy EB, Ürün M, Çay Şenler F, Ürün Y, Tuncay G, Ergün H, Akbulut H. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients. Support Care Cancer 2017 Jan;25(1):229-236. Epub 2016 Sep 12. doi:10.1007/s00520-016-3409-6.
1.a.3. Alkan A, Karcı E, Yaşar A, Tuncay G, Köksoy EB, Ürün M, Şenler FÇ, Demirkazık A, Utkan G, Akbulut H, Ürün Y. Vaccination in oncology practice and predictors. Support Care Cancer. Support Care Cancer. 2017 Sep;25(9):2677-2682. doi: 10.1007/s00520-017-3675-y. Epub 2017 Mar 22.
1.a.4. Mizrak Kaya D, Ozturk B, Kubilay P, Onur H, Utkan G, Cay Senler F, Alkan A, Yerlikaya H, Koksoy EB, Karci E, Demirkazik A, Akbulut H, Icli F. Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer. Future Oncol. 2018 Jun;14(15):1461-1467. doi: 10.2217/fon-2017-0608. Epub 2018 May 9.
1.a.5.Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study.
Bilir C, Yıldız İ, Bilici A, Ucar M, Berk V, Yıldız Y, Yazıcı O, İmamoğlu Gİ, Karadurmuş N, Pilancı KN, Arpacı E, Tanrıverdi Ö, Karcı E, Temiz S, Nayır E, Oktay E, Dal P , Petekkaya İ, Varım C, Cinemre H.Cancer Invest. 2017 Apr 21;35(4):248-255
1.a.6. Oktay E, Levent M, Gelincik H, Aktaş G, Yumuk F, Koral L, Arpacı E, Keser M, Alkan A, Karci E, Karadurmuş N, Degirmencioglu S, Turan M, Uyeturk U, Cabuk D1, Avci N, Toprak O , Ergen A, Urvay S, Bayman E, Petekkaya E, Nayir E, Paydaş S, Yavuzsen T, Senler FC, Yaren A, Barutca S, Şahinler İ, Ozyilkan O, Tanriverdi O. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments , Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)J Cancer Educ. 2018 Nov 16. doi: 10.1007/s13187-018-1441-6.
…………………………………………………………………………………………………………………………… ..
B. Papers presented at international scientific meetings and published in proceedings:
B1. 1.b.1. Alkan A, Köksoy EB, Karcı E, Burgaç H, Arıkanoğlu Soğancı A, YAman D, Çay Şenler F. Posttraumatic growth and death anxiety in caregivers of cancer patients: Phoenix Study. ESMO 2018 annual Meeting, Munich 2018.
1.b.2. Alkan A, A. Yaşar, ZG Güç, M. Gürbüz, T. Başoğlu, S. Sezgin Göksu, F. Buğdaycı Başal, HM Türk, Ö. Özdemir, H. Yeşil Çınkır, DC Güven, T. Kuş, S. Türker, L. Koral, Y. Karakaş, N. Ak, S. Paydaş, E. Karcı, Ö. Tanrıverdi, F. Çay Şenler. Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the palliative care working committee of the Turkish Oncology Group (TOG) ESMO 2019 annual Meeting, Barcelona 2019.
1.b3. Alkan A, Yasar A, Karcı E, Koksoy EB, Urun M, Cay Senler F, Urun Y, Ergun H, Akbulut H. Severe drug interactions and potentially inappropriate medication usage in elderly patients with cancer. ASCO 2016 Annual Meeting. J Clin Oncol 34, 2016 (suppl; abstr 10056).
1.b.4. Karcı E, Köksoy EB, Alkan A, Dede İ, Tuncay G, Utkan G, Ürün Y, Akbulut H. Predictive factors of lymph node metastasis in patients with non-metastatic colorectal adenocarcinoma. ESMO 2016 Annual Meeting.
1.b.5. Alkan A, Mızrak D, Karcı E, Yaşar A, Köksoy EB, Ürün M, Kütük T, Ürün Y, Çay Şenler F, Akyürek S, Utkan G, Demirkazık A, Gökçe SÇ, Akbulut H. Adjuvant concurrent chemoradiotherapy(CRT) plus docetaxel-cisplatin-fluorouracil (DCF) versus CRT plus fluorouracil folinic acid (FUFA) in gastric cancer. ESMO 2016 Annual Meeting.
1.b.6. Alkan A, Karcı E, Yaşar A, Tuncay G, Ürün M, Köksoy EB, Ürün Y, Çay Şenler F, Utkan G, Demirkazık A, Akbulut H. Medical oncologists’ attitudes towards vaccination in oncology practice. ESMO 2016 Annual Meeting.
…………………………………………………………………………………………………………………………… ..
C. Written national/international books or chapters in books:
C1. National/international books written:
C1.1. ……………………………………………………………………………………………………………………………
C2. Chapters in written national/international books:
C2.1.Karcı E, Non-urothelial Bladder Cancers, Chapter 19, Current Treatment Approaches in Oncology 2, Academician Kitabevi, 2019
2.2.Karcı E, Genetic and Epigenetic Changes in Lung Cancer, Part 2, Thorax Tumors, Academician Kitabevi, 2019
D. Articles published in national refereed journals:
D1. Alkan A, Kütük T, Karcı E, Yaşar A, Geçsönmez A, Utkan G. Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia. Turk J Haematol. 2016 Sep 5;33(3):248-50. doi: 10.4274/tjh.2015.0259. Epub 2016 Apr 18
…………………………………………………………………………………………………………………………… ..
E. Papers presented at national scientific meetings and published in proceedings books:
E1.1.e .1Alkan A, Guc ZG, Senler FC, Yavuzsen T, Onur H, Dogan M, Karci E, Yasar A, Koksoy EB, Tanriverdi O, Turhal S, Urun Y, Ozkan A, Mizrak D, Akbulut H .The relationship between post-mastectomy pain syndrome and post-traumatic stress disorder in operative breast cancer patients in complete remission
(ORTHUS Study)- Turkish Oncology Group (TOG), 6th Turkish Medical Oncology Congress, 23-27 March, 2016, Antalya, Turkey
1.e.2. Alkan A, Yaşar A, Karcı E, Köksoy EB, Ürün M, Çay Şenler F, Ürün Y, Tuncay G, Ergün H, Akbulut H.Serious drug interactions and inappropriate drug use in geriatric cancer patients.
6 Turkish Medical Oncology Congress., 23-27 March2016, Antalya, Turkey
1.e.3. Alkan A, Karcı E, Yaşar A, Tuncay G, Köksoy EB, Product M, Şenler FÇ, Demirkazık A, Utkan G, Akbulut H, Product Y
Vaccination and affecting factors in oncology practice. 22.National Casncer Congress, 19-23 April, 2017, Antalya, Turkey
1.e.4. Alkan A, Mızrak D, KArcı E, Yaşar A, Köksoy EB, Product M, Kütük T, Product Y, Çay Şenler F,
Akyürek S, Utkan G, Demirkazık A, Gökçe SÇ, Akbulut H. Efficacy of docetaxel-cisplatin-fluorouracil (DCF) regimen in the treatment of stage III gastric cancer adjuvant
22.National Casncer Congress, 19-23 April, 2017, Antalya, Turkey
1.e.5. Alkan A, Hande Selvi Öztorun, Ebru Karcı, Yüksel Ürün, Gülseren Tuncay, Arzu Yaşar, Esat Çınar, Sevgi Aras, Murat Varlı, Filiz Çay ŞenlerEvaluation of loneliness and cognitive functions in geriatric patients with and without cancer. 22.National Casncer Congress, 19-23 April, 2017, Antalya, Turkey
1.e.6. Çay Şenler F, Deniz O, Alkan A, Karcı E, Gülsüm Güç Z, Yavuzşen T, Doğan M, Karakaş Y, Kılıçkap S. Job satisfaction of cancer patients followed and in complete remission and the factors affecting this
TurkishOncology Group (TOG) Supportive Treatments subgroup Study. 22.National Casncer Congress, 19-23 April, 2017, Antalya, Turkey
1.e.7. Product M, Alkan A, Karcı E, Cansız Ersöz C, Product Y, Köksoy EB, A case of breast cancer metastasized to the endometrium.
6.Turkish Medical Oncology Congress, 23-27 March 2016, Antalya, Turkey
1.e.8. Karcı E, Alkan A, Köksoy EB, Yaşar HA, Ürün M, Cansız Ersöz C, Çay Şenler F. Prostate cancer case presenting with sternal mass
. 6 Turkish Medical Oncology Congress, 23-27 March 2016, Antalya, Turkey

Contact us via WhatsApp
1